Jianwei Zhang

EBV-driven LMP1 and IFN-γ up-regulate PD-L1 in nasopharyngeal carcinoma: Implications for oncotargeted therapy

Wenfeng Fang, Jianwei Zhang, Shaodong Hong et al. · Oncotarget · 2014 · 382 citations · Full text

Immunology, Immune Regulation, Cell Death +22

Remodeling of the immune and stromal cell compartment by PD-1 blockade in mismatch repair-deficient colorectal cancer

Jianxia Li, Cheng Wu, Huabin Hu et al. · Cancer Cell · 2023 · 290 citations · Full text

Cancer Immunosurveillance, Pd-1 Blockade, Medicine +9

Neoadjuvant PD-1 blockade with toripalimab, with or without celecoxib, in mismatch repair-deficient or microsatellite instability-high, locally advanced, colorectal cancer (PICC): a single-centre, parallel-group, non-comparative, randomised, phase 2 trial

Huabin Hu, Liang Kang, Jianwei Zhang et al. · ˜The œLancet. Gastroenterology & hepatology · 2021 · 278 citations

Neoadjuvant Pd-1 Blockade, Medicine, Immunology +7

<p>m<sup>6</sup>A methyltransferase METTL3 suppresses colorectal cancer proliferation and migration through p38/ERK pathways</p>

Ru Deng, Yi‐Kan Cheng, Shubiao Ye et al. · OncoTargets and Therapy · 2019 · 155 citations · Full text

Association of renal injury with nitric oxide deficiency in aged SHR: Prevention by hypertension control with AT1 blockade

Xin Zhou, Nosratola D. Vaziri, Jianwei Zhang et al. · Kidney International · 2002 · 63 citations · Full text

At1 Blockade, Hypertension, Urology +12